Q1 2026 Nano-X Imaging Ltd Earnings Call Transcript
Key Points
- Nano X Imaging Ltd (NNOX) is beginning to see early signs of revenue from its Nanox.ARC systems, indicating initial market traction.
- The company has restructured its US commercial model to emphasize partnerships, securing multiple commercial agreements with established medical equipment distributors.
- Deployments of Nanox.ARC systems are increasing, with strategic placements at high-visibility sites like RadNet, the largest outpatient imaging center operator in the US.
- The company is exploring opportunities in segments with potentially higher reimbursement rates, such as workers' compensation groups and concierge medical providers.
- Nano X Imaging Ltd (NNOX) has initiated a restructuring process to optimize its cost structure, improve capital efficiency, and reduce burn rates, aligning operations with long-term business objectives.
- The company no longer expects to achieve its previously announced 2026 revenue targets due to longer-than-anticipated timelines for commercialization and revenue recognition.
- Management has expressed concerns about the company's ability to continue as a going concern due to insufficient cash reserves to support operations for at least one year.
- There is substantial doubt about the company's ability to secure additional funding, which may lead to dilution of shareholder value or unfavorable financing terms.
- The transition from signed agreements to active sales and revenue recognition is slow, affected by factors such as site readiness and regulatory processes.
- Nano X Imaging Ltd (NNOX) has decided not to provide annual revenue guidance going forward, which may reduce transparency for investors.
Good day, and thank you for standing by. Welcome to the Nano-X first quarter 2026 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mike Cavanaugh, Investor Relations. Please go ahead.
Good morning, and welcome to the Nano-X Imaging first quarter 2026 investor call. Earlier today, Nano-X Imaging Ltd. released financial results for the quarter ending March 31, 2026. The release is currently available on the Investors section of the company's website. With me today are Erez Meltzer, Chief Executive Officer and Acting Chairman.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities regulatory process and clinical activities and other matters. These statements are subject to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
